Evidence map›Paper›PMID 41436816›Full record

ArticleScientific reports2025

Antiviral potential of crude extracts from two Streptomyces spp. against Cucumber Mosaic Virus infection under greenhouse conditions.

Hadeel Osama, Mohamed E El Awady, Radwan R Khalil, Amro A Farrag, Ahmed A Hamed, Mohamed A Nasr-Eldin

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hadeel OsamaDepartment of Botany and Microbiology, Faculty of Science, Benha University, Benha, 13511, Egypt.
Mohamed E El AwadyDepartment of Microbial Biotechnology, National Research Centre, Giza, Egypt.
Radwan R KhalilDepartment of Botany and Microbiology, Faculty of Science, Benha University, Benha, 13511, Egypt.
Amro A FarragVirus and Phytoplasma Research Department, Plant Pathology Research Institute, Agricultural Research Center (ARC), Giza, 12619, Egypt.
Ahmed A HamedMicrobial Chemistry Department, National Research Centre, Dokki, Cairo, 12622, Egypt.
Mohamed A Nasr-EldinDepartment of Botany and Microbiology, Faculty of Science, Benha University, Benha, 13511, Egypt. mohamed.nasreldin@fsc.bu.edu.eg.ORCID 0000-0002-8537-9392

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine actinomycetes are a promising source for developing new antiviral agents for plant diseases, as they produce a wide variety of bioactive compounds. To date, antiviral activity of marine actinomycetes against plant viruses are rare. The present study proceeded to identify and characterize promising antiviral actinomycetes from Red Sea in Hurghada, Egypt, control Cucumber Mosaic Virus (CMV) and, profile the individual chemical components of bioactive crude extracts. Biological and molecular characterization was performed to identify CMV isolate using RT-PCR and coat protein (CP) gene nucleotide sequences analysis. In squash plants, antiviral, CMV optical density, biochemical responses, and resistance genes expression of Streptomyces extracts (SE1 and SE2) were performed against CMV by disease incidence, severity (%) assays, ELISA technique, physiological analysis, and real-time quantitative PCR (qPCR). Chemical profiling of the two Streptomyces extracts was investigated using GC-MS analysis. Antiviral activity was performed by curative (C), protective (P), and inactivation (I) techniques under greenhouse conditions. The obtained results of the morphological, biochemical, physiological and molecular level studies of the Streptomycetes isolates ph6 and MARH showed similarity towards the species of Streptomyces and identified as Streptomyces variabilis strain ph6 (OQ283766) and Streptomyces sp. strain MARH (OQ283775). Protective treatments (P: SE1 and P: SE2) resulted in disease suppression of 100%, while curative treatments (C: SE1 and C: SE2) by 87% and 100%, and inactivation treatments (I: SE1 and I: SE2) by approximately 70%, and 80% respectively compared to mock-inoculated plants. The absorbance values of ELISA at 405 nm for P: SE1 and P: SE2 were 0.191 ± 0.02, and 0.187 ± 0.00 respectively compared to CMV-infected plants which recorded 0.854 ± 0.00. Levels of ascorbate peroxidase (APX), catalase (CAT) enzymes, proline content, total photosynthetic pigments, and total phenolic compounds were significantly increased in P: SE1 and P: SE2 treated squash plants compared to CMV-infected plants. Moreover, P: SE1 and P: SE2 increased membrane stabilization and reduced electrolyte leakage. The pathogenesis-related (PR) gene such as PR-b1 was overexpressed by about 3.09-, and 10.37-fold increases and PR-2 by 1.07-, and 1.66-fold increases for P: SE1 and P: SE2 respectively compared to the CMV-infected control group. Chemical profiling of the ethyl acetate extracts of Streptomyces variabilis and Streptomyces sp. MARH authenticated the presence of constituents such as 1,3¬Dinitro¬2-imidazolidinone (42.60%), Nephthoside-1,2',3',4'-Tetraacetate (76.18%), Tetraphenylporphyrinato dichlorotitanium(IV) (12.42%) and L-Lysine (17.01%) respectively. Our results showed that Streptomyces variabilis and Streptomyces sp. MARH are promising strains for production of antiviral natural products, increasing the phenolic compounds, activity of the antioxidant enzymes, and induction the expression of pathogenesis-related genes to generate systemic acquired resistance (SAR) in squash plants. They also supported the potential use of their extracts as an environmentally friendly novel bio-virocides to sustainably stop the spread of plant viruses.

Indexed as

Antiviral AgentsComplex MixturesCucumovirusPlant DiseasesStreptomycesAntiviral AgentsComplex MixturesCMVControlEthyl acetate extractsGC–MSMarine actinomycetesPathogenesis-related genesPhysiology

Identifiers

PMID41436816
PMCPMC12728196

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.